Contact this trialFirst, we need to learn more about you.
Tyrosine Kinase Inhibitor
Neratinib + Capmatinib for Breast Cancer
Recruiting3 awardsPhase 1 & 2
Houston, Texas
This trial is to study if the drugs capmatinib and neritinib can help control metastatic or locally advanced breast cancer, as well as to find the highest tolerable dose of the combination therapy.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.